MADAUDO, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 1.955
EU - Europa 1.893
AS - Asia 1.538
Continente sconosciuto - Info sul continente non disponibili 419
SA - Sud America 292
AF - Africa 53
OC - Oceania 7
Totale 6.157
Nazione #
US - Stati Uniti d'America 1.826
IT - Italia 769
RU - Federazione Russa 572
SG - Singapore 507
CN - Cina 303
BR - Brasile 219
BD - Bangladesh 203
VN - Vietnam 194
PL - Polonia 117
HK - Hong Kong 101
FI - Finlandia 90
DE - Germania 88
FR - Francia 68
JP - Giappone 62
CA - Canada 57
GB - Regno Unito 52
NL - Olanda 47
IN - India 37
AR - Argentina 35
MX - Messico 26
IQ - Iraq 19
SE - Svezia 19
TR - Turchia 16
ZA - Sudafrica 14
PK - Pakistan 12
AT - Austria 11
ES - Italia 11
PH - Filippine 10
ID - Indonesia 9
EC - Ecuador 8
AL - Albania 7
CR - Costa Rica 7
CU - Cuba 7
DZ - Algeria 7
HN - Honduras 7
IE - Irlanda 7
KR - Corea 7
TN - Tunisia 7
UZ - Uzbekistan 7
CL - Cile 6
CO - Colombia 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
JM - Giamaica 5
MY - Malesia 5
PE - Perù 5
PR - Porto Rico 5
TW - Taiwan 5
VE - Venezuela 5
EG - Egitto 4
GR - Grecia 4
GT - Guatemala 4
MA - Marocco 4
RO - Romania 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
KZ - Kazakistan 3
LY - Libia 3
TH - Thailandia 3
BB - Barbados 2
CZ - Repubblica Ceca 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
YE - Yemen 2
AM - Armenia 1
BM - Bermuda 1
CH - Svizzera 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 5.729
Città #
San Jose 324
Singapore 319
Ashburn 305
Council Bluffs 137
Zgierz 99
Hong Kong 98
Milan 89
Los Angeles 87
Moscow 86
New York 79
Palermo 78
Rome 73
Dallas 67
Ho Chi Minh City 62
Helsinki 61
Tokyo 59
Hanoi 49
Hefei 44
Beijing 43
Santa Clara 42
Buffalo 37
Lauterbourg 37
Boardman 27
Lappeenranta 25
Chicago 24
Naples 22
Frankfurt am Main 19
Munich 18
São Paulo 18
The Dalles 18
Toronto 18
Bari 17
Chandler 17
London 17
Amsterdam 16
Da Nang 16
Shanghai 16
Brooklyn 15
Atlanta 14
Bologna 14
Montreal 13
Nuremberg 13
Orem 12
Warsaw 12
Mexico City 11
Phoenix 11
Catania 10
Denver 10
Seattle 10
Charlotte 9
Houston 9
Hải Dương 9
Padua 9
Buenos Aires 8
Ludwigshafen am Rhein 8
Venice 8
Chennai 7
Curitiba 7
Dublin 7
Florence 7
Havana 7
Parma 7
Stockholm 7
Tirana 7
Belo Horizonte 6
Columbus 6
Fort Wayne 6
Goiânia 6
Guangzhou 6
Haiphong 6
Hillsboro 6
Redondo Beach 6
San Francisco 6
Vienna 6
Boston 5
Cambridge 5
Falkenstein 5
Greensboro 5
Guayaquil 5
Johannesburg 5
Manaus 5
Monza 5
Philadelphia 5
Poplar 5
Querétaro 5
Salt Lake City 5
San Diego 5
San José 5
Shenzhen 5
Tashkent 5
Verona 5
Albuquerque 4
Baku 4
Brussels 4
Cagliari 4
Cape Town 4
Duque de Caxias 4
Erbil 4
Fairfield 4
Guatemala City 4
Totale 3.005
Nome #
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity 294
ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes. 284
A possible easy way to predict response to cardiac resynchronization therapy: The role of QRS Index 208
Assessment of cancer therapy-related cardiac dysfunction in breast cancer women using a new speckle tracking echocardiography index: The GAVS 181
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice 180
Exploring the role of Glial Fibrillary Acid Protein (GFAP) in Acute coronary syndrome 170
Arterial Stiffness: Effects of Anticancer Drugs Used for Breast Cancer Women 158
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 146
Left Ventricular Deformation and Myocardial Work Parameters in Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran: A Single-Center Study 145
Role of Lipoprotein Ratios and Remnant Cholesterol in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) 137
Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions. 134
Longitudinal Strain Analysis and Correlation with TIMI Frame Count in Patients with Ischemia with No Obstructive Coronary Artery (INOCA) and Microvascular Angina (MVA) 130
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question 128
Impact of Metabolic Syndrome on Coronary Microvascular Dysfunction: A Single Center Experience 127
The added value of the HFA/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer 126
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis 124
Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices 124
Management of a patient with multiple device replacements and extractions: When the leadless pacemaker is a viable solution 124
Contractile Reserve in Heart Failure with Preserved Ejection Fraction 121
Coronary Revascularization in Patients with Hemophilia and Acute Coronary Syndrome: Case Report and Brief Literature Review 117
Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction 116
Right ventricle involvement in patients with breast cancer treated with chemotherapy 116
Dysfunctional High-Density Lipoprotein Cholesterol and Coronary Artery Disease: A Narrative Review 111
The Impact of Triglyceride-Glucose (TyG) Index on Future Cardio and Cerebrovascular Events in Patients with Acute Coronary Syndrome, During 3 Years of Follow-Up 106
Higher Incidence of Cancer Therapy-Related Cardiac Dysfunction in the COVID-19 Era: A Single Cardio-Oncology Center Experience 98
Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology) 96
Optimal Timing of Angiography-Guided Complete Revascularization of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 95
Cancer survivors and cardiovascular diseases: from preventive strategies to treatment 93
Gastrointestinal Bleeding During Long-Term Left Ventricular Assist Device Support: External Validation of UTAH Bleeding Risk Score 93
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy 92
The ANOCA/INOCA Dilemma Considering the 2024 ESC Guidelines on Chronic Coronary Syndromes 92
Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis 89
The Genetic Puzzle of the Stress-Induced Cardiomyopathy (Takotsubo Syndrome): State of Art and Future Perspectives 89
Prognosis of myocarditis stratified by initial clinical presentation: Does "intermediate" risk still play a role? 88
SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction 79
Blood Cell Subtype patterns in Takotsubo Syndrome and acute coronary syndrome: analysis from the GEIST registry 79
Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice 78
Improving cardiovascular health today to prevent heart failure tomorrow: the importance of a holistic approach 77
Multimodality Assessment for Durable Mechanical Circulatory Support Implantation 74
Tricuspid transcatheter edge-to-edge repair for severe symptomatic tricuspid regurgitation: a systematic review and meta-analysis 74
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 73
Neutrophil‐to‐lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum 72
Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions 70
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies 70
Right Ventricular Function and Ventricular–Arterial Coupling in HFpEF and HFmrEF Treated With SGLT2 Inhibitors: A Multicenter Echocardiographic Analysis From the DISCOVER-SGLT2i Registry 69
Denosumab for cancer-related bone loss 66
Tighter is better: Can a simple and cost‐free parameter predict response to cardiac synchronization therapy? 60
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 56
The Role of Inflammation in Takotsubo Syndrome: From Pathogenic Pathways To Imaging Insights and Therapeutic Perspectives 53
2017 Marathon of Rome: Anthropometry and Sport Profile in 350 Runners and Association With Achilles and Patellar Tendinopathy 44
Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunction 42
Corrigendum to:“The changing landscape of Heart Failure: translating management into the modern era”(European Journal of Internal Medicine, (2025), (106633), (S0953620525005102), 10.1016/j.ejim.2025.106633) 41
Current and future landscape of heart failure management: understanding the present, unraveling the future 39
Are We Ready to Monitor the Atrium? From Ventricular-Centric to Chamber-Integrated Cardiotoxicity Surveillance: The Emerging Role of Left Atrial Strain 39
QRS Index as a Predictor of Response to Cardiac Resynchronization Therapy: A Systematic Review and Meta-Analysis 37
The Quantitative Haemodynamic Effect of Levosimendan, Dobutamine and Milrinone in Heart Failure Patients: a Meta-Analysis 37
Burnout Among Italian Medical Doctors: A Cross-Sectional Study on Emotional Exhaustion, Depersonalization, and Gratification Post-COVID-19 30
Interleukin-1 Blockade in Myocardial Infarction and Its Efficacy in Patients With Complex Coronary Artery Disease: Another Brick in the Wall 29
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence 27
The changing landscape of heart failure: translating management into the modern era 27
Impact of Insulin Resistance and Preclinical Atherosclerosis Parameters in Long-Term Prediction of Cardiovascular Events: A Seven-Year Prospective Study 23
Management of Bleeding Disorder During Dual Antiplatelet Therapy 20
Patient profiles and outcomes of chronic total occlusion percutaneous revascularisation in middle- and high-income regions a cross-sectional study from the European Registry of Chronic Total Occlusions (ERCTO) 18
Percutaneous coronary intervention or conservative therapy for chronic total coronary occlusions (CTOs)? Evidence from the ISCHEMIA trial 18
Vericiguat in heart failure with reduced ejection fraction: toward a new paradigm of residual risk and worsening heart failure 15
First quinquennium completed: highlights from EHJ Open 2025 15
Myocarditis Prognostic Score: A New Risk Assessment Tool 14
When cancer meets acute coronary syndrome: moving beyond the ‘cancer disadvantage’ 13
Arrhythmias in patients with cancer: Pathophysiology, risk stratification and clinical implications: Brief title: Arrhythmias in Patients with Cancer 12
Bruton tyrosine kinase inhibitors and cardiovascular adverse events 12
Percutaneous Retrieval of an Embolized Catheter Fragment in Right Heart Chambers in Pinch-Off Syndrome and Subsequent Reimplantation: Nurse’s Role in Interventional Cardiology—A Case Report 12
Burnout among Italian Healthcare Professionals: A Cross-Sectional Study on Emotional Exhaustion, Depersonalization, and Gratification Post-COVID-19 11
Totale 6.157
Categoria #
all - tutte 19.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 0 5 3 9 6 7
2022/2023145 3 10 1 5 6 11 14 43 22 4 6 20
2023/2024195 3 16 20 28 10 28 14 4 2 7 37 26
2024/2025849 17 16 43 81 29 29 133 74 65 93 114 155
2025/20264.305 175 181 275 442 449 499 514 469 384 247 337 333
2026/2027633 265 285 83 0 0 0 0 0 0 0 0 0
Totale 6.157